Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29200| Title: | COVID-19 and toxicity from potential treatments: Panacea or poison. | Authors: | Wong A. | Monash Health Department(s): | Monash University - School of Clinical Sciences at Monash Health | Institution: | (Wong) Victorian Poisons Information Centre, Austin Toxicology Unit and Emergency Department, Austin Health, Melbourne, VIC, Australia (Wong) Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia (Wong) Centre for Integrated Critical Care, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia | Issue Date: | 30-Jul-2020 | Copyright year: | 2020 | Publisher: | Blackwell Publishing | Place of publication: | Australia | Publication information: | EMA - Emergency Medicine Australasia. 32 (4) (pp 697-699), 2020. Date of Publication: 01 Aug 2020. | Journal: | EMA - Emergency Medicine Australasia | Abstract: | Since December 2019, coronavirus disease (COVID-19) has been increasingly spreading from its origin in Wuhan, China to many countries around the world eventuating in morbidity and mortality affecting millions of people. This pandemic has proven to be a challenge given that there is no immediate cure, no vaccine is currently available and medications or treatments being used are still undergoing clinical trials. There have already been examples of self-medication and overdose. Clearly, there is a need to further define the efficacy of treatments used in the management of COVID-19. This evidence needs to be backed by large randomised-controlled clinical trials. In the meantime, there will no doubt be further off-label use of these medications by patients and practitioners and possibly related toxicity.Copyright © 2020 Australasian College for Emergency Medicine | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/1742-6723.13537 | PubMed URL: | 32378805 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32378805] | ISSN: | 1742-6731 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/29200 | Type: | Article | Subjects: | bone marrow suppression China coma convulsion coronavirus disease 2019 diarrhea drug efficacy drug overdose drug research evidence based medicine gastrointestinal symptom headache heart arrhythmia hypertransaminasemia hypokalemia hypotension kidney dysfunction liver injury pancreatitis pandemic patient safety QT prolongation rash self medication virus load virus transmission activated carbon azithromycin [Adverse Drug Reaction] drug intoxication azithromycin ceftriaxone chloroquine [Adverse Drug Reaction] chloroquine atrioventricular block colchicine hydroxychloroquine [Adverse Drug Reaction] hydroxychloroquine ivermectin lopinavir plus ritonavir [Adverse Drug Reaction] lopinavir plus ritonavir remdesivir [Adverse Drug Reaction] remdesivir thalidomide tocilizumab [Adverse Drug Reaction] tocilizumab |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.